We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Lon.Asia China | LCP | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 13.00 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 13.00 | 13.00 |
| Top Posts |
|---|
Posted at 06/11/2008 10:29 by robizm Investors Chronicle when they covered the results. Not that I would buy for more than 10p myself. |
Posted at 09/10/2008 15:38 by handycam just spotted this on sharecrazy:LCP The Plot Thickens. Back in June I warned investors about the pompous-sounding London Asia Capital Private Equity Fund (AIM LCP). The published NAV was then 136p and the share price 75p. The share price is now 35p and the latest reported NAV is 143p. The market's refusal to believe in the stated NAV is understandable. The new auditors (the old ones resigned ) explain that the groups 14 illiquid assets are valued using "a variety of methods and makes assumptions based on the market conditions at the end of each balance sheet date" or to translate the valuations are what the directors tell us they are. Of the groups four investments listed on PLUS at the balance sheet date one, China New Energy (the groups largest single investment) has since been suspended, and two of the others China Biofuels and Dalian have not submitted audited accounts to Plus as required under the rules. What is perhaps most strange is that the group has booked through the P&L a\c around £7mn in performance fees due to its "investment consultant"London Asia Capital in the last two years of which the cash flow statement shows £3.1mn to have been paid already. London Asia Capital is suspended on Aim due to the non appearance of its accounts and its new CEO seems unclear as to where this money has gone. London Asia Capital has no executive directors and on my last look was being run from a language school in Falmouth Cornwall. Trying to find who exactly at the company is providing £7mn of advice to its client in two years is proving somewhat problematic. To recap: the company,s performance and the record keeping of the companies in which it has invested is highly questionable and the whereabouts of the fees it has paid out to its investment consultant are unknown by that consultant's own CEO. If this isn't one for AIMs regulators, I don't know what is. |
Posted at 18/9/2008 13:14 by egoi I wouldn't put too much store by their fair value assessments. Infact personally I have never seen a company make such sweeping statements as to give such wide estimates (the 72.3 million is in the middle of the range 58-88 million).China New Energy Limited holding for example is valued at 10-15 million. CNE is currently suspended on Plus, so that's about 12 million we can knock off straight away and unless lifted by end September should show as zero in the interims! As for the 'Our on the ground presence and over ten years' experience of operating in China, including through the last recession, puts us in a better position to identify opportunities and risks, and take advantage of the various sources of liquidity within China, as the traditional financial centres and less experienced investors struggle.....' I consider that to be utterly pompous bullsh*t. By less experienced are Victor and Simon referring to LDC? Oh I forgot they were the fellas running that one too.......... |
Posted at 13/6/2008 11:40 by egoi Robsy I wish you luck, however I fear you will need shedloads, and that might not be enough imho.The repeated - and deeply disturbing - accounting failures of people involved also with this company, imho, should be enough for any investor to believe there are better places for their money. I suggest you have a read of the LDC thread more thoroughly. We have had posters before on these companies threads who some think are related to management. Your last post makes me wonder!! |
Posted at 13/6/2008 11:31 by robsy2 egoiHeh heh! Again joking aside, I admit I am a bit flummoxed by this one.I exited LDC some time ago money, more or less intact.LDC needs money, so they need to exit LCP investments and get some of the fees pending. I will see how it plays out, it trades at a deep discount,though it always seems to track down with the Chinese market,it never tracks up. Has a decent roster of Institutional investors as well which could provide some comfortand what looks to be a red hot set of investments....... |
Posted at 05/11/2007 15:16 by robsy2 Here is what IC has to say;It's easy to confuse London Asia Chinese Private Equity (LAE) with its sister company London Asia Capital (LAC). Both have a similar management, their investment aims are the same, they share two common investments - and both their share prices have wilted because of regulatory changes in China. Advertising Starting in September 2006, the Chinese government brought in regulations to restrict the ability of non-Chinese investors to acquire assets in China. Tax preferences for foreign-invested businesses have been removed, and Chinese companies that accept foreign rather than local money risk being unable to list in China, where valuations can be much higher. These changes don't appear to be good news for LAE. But the company is putting on a brave face, saying that its portfolio will now be more valuable to outside investors. But the share price does not agree as yet - although a switch in emphasis from new investments to realising investments may change sentiment when it happens. LAE holds a number of Plus-listed shares; its largest shareholding at end-March 2007 was a £12.7m fair-value stake in China New Energy. It provides equipment to produce raw alcohol from which "edible alcohol", fuel ethanol and acetic acid can be produced. LAE does not think that its shareholders will want to follow the same course as those in its sister operation, which offers its investors direct shareholdings in Plus-quoted shares. LONDON ASIA CHINESE PRIVATE EQUITY FUND (LCP) ORD PRICE: 108p MARKET VALUE: £ 54.0m TOUCH: 107-109 12-MONTH HIGH: 124.5p LOW: 107.5p DIVIDEND YIELD: NIL PE RATIO: 3 Year to 31 Mar Net asset value (p) Pre-tax profit (£m) Earnings per share (p) Dividend per share (p) 2007* 133.05 18.4 36.75 nil * 14 months. IC VIEW BuyAt this bombed out level, the shares are a speculative buy for the brave. Last IC View: Good value, 115p, 12 January 2007 |
Posted at 17/5/2007 10:21 by damanko Phbat - agree, seems interesting. I invested a small lump sum a few months ago, and buy a regular amount through an investment scheme. Couple of points - everything seems to point to a pretty large market correction looming on the Chinese market, looking forward to seeing how LCP copes with that. Also, this stock seems very quiet on the private investor front, not just regarding posts on here (which can be a good thing). But also the volumes traded. Other than the odd RNS with institutions taking up holdings, there is little in the way of trades. In fact each month I can check the paltry amount I purchase through the main LSE page, without having to trawl through page after page of daily trades on ADVFN or similar sites. I'm looking long term on this, and would like to build up a holding fairly close to the original placing price, 5 years plus LCP could look a lot more interesting, they seem to have good local knowledge on board. Still wonder about the lack of private investor activity though........ |
Posted at 12/1/2007 07:46 by buffin From the LDC board.rivaldo - 11 Jan'07 - 20:55 - 7370 of 7370 LCP receive a "Good value" verdict from the IC: "The London Asia Chinese Private Equity Fund has only been going since March, but already there has been a slight change of emphasis. The early investments went to a hotch-potch of sectors, from property services to metal packaging. But since September it has focused on renewable energy. Investments include a solar energy company, a wind energy company and an emissions advisory company. The move is partly down to a change in regulations. China's government has made it harder for overseas investors to put money into Chinese companies, but the renewable energy sector is exempt from the change. The fund raised £48m (net) when it was launched and has so far spent £32.5m of it on 11 deals - there's already a £10m profit on those deals. It has commitments to spend the rest of its cash so a further fundraising is likely." "Trading at roughly the fund's 117p net asset value doesn't look so cheap. But there's plenty of potential and fund has been avoided some of the flak directed at Aim's Chinese plays as it's run by London Asia Capital, which has 32 offices in China. Such backing is more than many other Chinese investments can offer. Good value." |
Posted at 29/11/2006 07:30 by boonboon China CDM Exchange CentreChina CDM Exchange Centre Limited ("CCEC") is a Jersey incorporated company providing brokerage, advisory and research services relating to the reduction of greenhouse gases ("GHGs") in Asia. It works with businesses and projects that generate carbon credits, and assists the project owner to identify buyers for, and sell on, those carbon credits. In addition to providing advice to projects which generate carbon credits, CCEC also acts as an emissions broker and maintains its own carbon trading portfolio. It manages the only on-line platform for environmental commodity transactions in China. The Company operates within the framework of the Clean Development Mechanism ("CDM") of the Kyoto Protocol, established under the auspices of the United Nations Framework Convention on Climate Change. The Protocol commits countries to reducing their emissions of GHGs by pre-determined amounts or compensate for maintained or higher GHGs emissions via emissions trading. Currently, CCEC is working on 26 projects with aggregate annual CO2 emissions of approximately 30 million tons. As the world's second largest emitter of GHGs, China is expected to overtake the US in GHGs emissions by 2025 and become the major player in the global carbon market. To date China is the largest CDM seller and the target for many of the carbon credit funds created in the last 18 months seeking to buy carbon credits. CCEC has applied for listing on PLUS market in December 2006. London Asia Corporate Finance Ltd is acting as the Corporate Adviser to CCEC in its application to PLUS listing. For additional information or an investor presentation (note: the offer is only available to those investors who have registered with us as Sophisticated Investors or High Net Worth Individuals, in accordance with UK Financial Services regulations), please contact carol.chen@londonasi |
Posted at 30/6/2006 07:32 by boonboon AcquisitionRNS Number:4253F London Asia Chinese Private Equity 30 June 2006 30 June 2006 London Asia Chinese Private Equity Fund Limited ("LACPEF" or "the Fund") Three new investments LACPEF, the China focused investment fund, announces that it has committed to make three new investments, for a total consideration of #6.9 million in cash. The Fund is investing #1.9 million in China New Energy Ltd ("CNE"), a leading turnkey provider of production equipment and technologies for ethanol production in China; #2.9 million in China Synergy Real Estate Limited ("Synergy"), a leading real estate services firm based in Beijing; and #2.1 million in China Biofoods, a health food products company. China New Energy: CNE's core business is the supply of turnkey technology solutions for the production of ethanol, edible alcohol and acetic acid from a range of bio-resources, including corn, sugarcane, cassava and other bio-resources. CNE has established itself as the leading brand in China, with an estimated 60% share of the market for ethanol production equipment in China. The Company's successful track record is key to growing the business and its leading technology has been used in over 30 projects. CNE is supported by strong drivers with the demand for ethanol, a fuel seen as an alternative to oil, still growing and supported by a new legislative framework requiring 10% of all vehicle oil consumption to be biofuel in 11 of China's Provinces. For the year ended 31 December 2005 CNE reported profit after tax of #1.9m (2004: #0.6m) on sales of #8.7m (2004: #3.1m). Based in Guangzhou, it was founded in June 2002 as a spin-out from the Renewable Energy division of China's Academy of Science, the leading Government funded centre in China for the development of renewable energy technology. CNE currently has 72 employees and following the investment from the fund, Simon Littlewood and Victor Ng, managers of the Fund, will take a seat on the Company's board. China Synergy: Synergy is the second largest real estate broker in the northern China market. Founded 10 years ago in Beijing, China, the Company provides agency, consultancy and conveyance services for property developers in China including international property investors Carlyle Partners and Lehman Bros. The Company focuses on deals with residential and commercial properties at the top end of the market, and has advised on 60 projects. Synergy was named as "Agency of the Year" in "New Real Estate", the industry magazine, and in the Top 20 Real Estate Agencies in China" in 2005 by "SINA.com ". For the year ended 31 December 2005 Synergy reported profit after tax of #2.1m on turnover of #4.9m, up 58% and 38% respectively on 2004. Simon Littlewood will be appointed to the Synergy Board following investment. China Biofoods: China Biofoods is based in Xuchang, Henan Province, the centre for farming traditional Chinese medical herbs. It specialises in the production of highly purified herb extract products which are then used to produce traditional Chinese medicine, and as ingredients in functional foods. The market for "Functional Foods" is expanding rapidly worldwide, especially in China. "Functional Foods" are foods or dietary components that may provide a health benefit beyond their basic nutritional value. China Biofoods' core products are highly purified linolenic acids, Reshi mushroom spore oil, and deodorized garlic oil. Linolenic acid, also known as Vitamin F, is an essential fatty acid which is not produced by the body, and has been proven to improve hair and skin, reduce blood pressure, help prevent arthritis, lower cholesterol & triglycerides and reduce the risk of blood clots. Reshi mushroom spore oil is broadly used in the health food industry as a supplement and intermediate ingredient. In 2005 China Biofoods reported revenues of #2.9m with profit after tax of #1.2m. The Fund will appoint a representative to the China Biofoods Board following investment. Victor Ng, Director of LACPEF, commented: "All three companies presented at London Asia's China Seminar in London earlier this month. There was strong interest from investors as all three sectors are showing considerable growth on the back of China's continued economic development. CNE is the leading player in is field and has significant growth potential as China seeks to develop renewable energy sources and reduce its reliance on expensive imported fossil fuels. Synergy is taking advantage of the switch from public and subsidised housing to the development of a private housing market in China, with the Beijing market seeing additional impetus from the 2008 Olympics. China Biofoods' products appeal to the increasingly affluent Chinese population, who have more money to spend than in the past and are becoming more health conscious, particularly as a result of the one child policy and the ageing of the population" Simon Littlewood, Director of LACPEF, added: "The Fund has now made five investments, totalling #9.3 million. There is potential to make follow on investments in those deals as the companies develop and we also have a number of other deals which we expect to close in the near future." For further information please visit www.londonasiafunds. John West/Matt Ridsdale Simon Littlewood Hugh Field Tavistock Communications London Asia Capital plc Collins Stewart Limited Tel: 020 7920 3150 Tel: 020 7355 7928 Tel: 020 7523 8000 This information is provided by RNS The company news service from the London Stock Exchange END ACQFLMRTMMATBFF |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
